MSLN and metastatic malignant neoplasm in the lymph nodes: In the MPM regional lymph node metastasis stage (N stage, Figure 6B), N0 subgroup showed that the higher the MSLN gene expression level, the longer the patient survival time, and the significant difference in the survival time distribution of the subgroups.